Kyverna Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIDA VENTURES ADVISORS, LLC | 11/03/2025 | 4.52 M | $27.14 M | 0.00% | 10.47% |
| GILEAD SCIENCES, INC. | 11/13/2025 | 4.13 M | $24.76 M | 0.00% | 9.55% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2025 | 3.37 M | $20.21 M | 0.00% | 7.79% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.51 M | $9.07 M | -17.39% | 3.50% |
| VANGUARD GROUP INC | 11/07/2025 | 1.32 M | $7.94 M | 0.75% | 3.06% |
| INSIGHT HOLDINGS GROUP, LLC | 11/14/2025 | 989.05 K | $5.93 M | 0.00% | 2.29% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 677.59 K | $4.07 M | -2.51% | 1.57% |
| MBB PUBLIC MARKETS I LLC | 11/14/2025 | 614.48 K | $3.69 M | 0.00% | 1.42% |
| CATALIO CAPITAL MANAGEMENT, LP | 11/14/2025 | 586.91 K | $3.52 M | 0.00% | 1.36% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 551.64 K | $3.31 M | 21.89% | 1.28% |
| BLACKROCK, INC. | 11/12/2025 | 482.05 K | $2.89 M | -9.64% | 1.12% |
| KERA CAPITAL PARTNERS, INC. | 10/27/2025 | 421.92 K | $2.53 M | 0.00% | 0.98% |
| PEAPOD LANE CAPITAL LLC | 11/10/2025 | 318.76 K | $1.91 M | -19.66% | 0.74% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 278.33 K | $1.67 M | -3.22% | 0.64% |
| WOODLINE PARTNERS LP | 11/14/2025 | 252.21 K | $1.51 M | 100.00% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 202.69 K | $1.22 M | 180.47% | 0.47% |
| JANE STREET GROUP, LLC | 11/14/2025 | 198.85 K | $1.19 M | 126.56% | 0.46% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 174.90 K | $1.05 M | 178.06% | 0.40% |
| MORGAN STANLEY | 11/14/2025 | 174.20 K | $1.05 M | -13.78% | 0.40% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 164.80 K | $988.78 K | -34.66% | 0.38% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 164.61 K | $987.68 K | 34.47% | 0.38% |
| UBS GROUP AG | 11/13/2025 | 157.42 K | $944.53 K | 60.38% | 0.36% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 147.71 K | $886.27 K | 100.00% | 0.34% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 132.45 K | $794.71 K | 9.84% | 0.31% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 125.58 K | $753.47 K | 5.88% | 0.29% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/14/2025 | 103.81 K | $622.85 K | -12.25% | 0.24% |
| STATE STREET CORP | 11/14/2025 | 91.30 K | $547.80 K | 0.00% | 0.21% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 81.30 K | $487.80 K | -13.79% | 0.19% |
| BARCLAYS PLC | 11/12/2025 | 76.19 K | $457.15 K | 51.19% | 0.18% |
| CITADEL ADVISORS LLC | 11/14/2025 | 67.70 K | $406.20 K | 72.26% | 0.16% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 64.96 K | $389.78 K | 92.45% | 0.15% |
| NORTHERN TRUST CORP | 11/14/2025 | 51.68 K | $310.07 K | 0.00% | 0.12% |
| XTX TOPCO LTD | 11/14/2025 | 49.11 K | $294.64 K | 40.55% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 46.90 K | $281.40 K | 63.99% | 0.11% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 43.13 K | $258.79 K | -68.37% | 0.10% |
| STIFEL FINANCIAL CORP | 11/12/2025 | 38.82 K | $232.93 K | -0.37% | 0.09% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 36.69 K | $220.15 K | 161.13% | 0.08% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 34.02 K | $204.13 K | 667.82% | 0.08% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 32.21 K | $193.23 K | 100.00% | 0.07% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 27.18 K | $163.06 K | -51.05% | 0.06% |
| CAXTON CORP | 11/14/2025 | 22.98 K | $137.89 K | 0.00% | 0.05% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 20.45 K | $122.68 K | -85.86% | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2025 | 19.44 K | $116.63 K | -46.37% | 0.05% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 10/31/2025 | 18.89 K | $113.36 K | -1.20% | 0.04% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 18.28 K | $109.68 K | 448.62% | 0.04% |
| CITADEL ADVISORS LLC | 11/14/2025 | 17.67 K | $106.00 K | -94.57% | 0.04% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 16.30 K | $97.80 K | 100.00% | 0.04% |
| ETHIC INC. | 10/17/2025 | 15.35 K | $92.12 K | -9.88% | 0.04% |
| FEDERATED HERMES, INC. | 11/03/2025 | 15.16 K | $90.95 K | -65.55% | 0.04% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 15.11 K | $90.65 K | 100.00% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kyverna Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 93 institutional investors and hedge funds held shares of Kyverna Therapeutics, Inc.. The most heavily invested institutionals were:
Vida Ventures Advisors, LLC: 4.52 M
GILEAD SCIENCES, INC.: 4.13 M
Bain Capital Life Sciences Investors, LLC: 3.37 M
PRICE T ROWE ASSOCIATES INC /MD/: 1.51 M
VANGUARD GROUP INC: 1.32 M
Insight Holdings Group, LLC: 989,054
52.51% of Kyverna Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 27.43 M shares in the last 24 months. This purchase volume represents approximately $151.41 M in transactions.